US and UK Tax Advisors Pre-IPO Equity Planning 2026 |

US and UK Tax Advisors Pre-IPO Equity Planning 2026 |

US and UK Tax Advisors: Pre-IPO Equity Planning 2026

US and UK Tax Advisors on Pre-IPO Equity Planning

A transatlantic founder who lists their UK-incorporated company on a US exchange without pre-IPO equity planning faces one of the most concentrated cross-border tax events in private company finance — a simultaneous UK capital gains tax charge, a US federal capital gains tax charge, a potential Section 1248 ordinary income recharacterisation on their CFC shares, and the possible loss of Business Asset Disposal Relief if the company's qualifying period is not correctly managed through the IPO structure. Furthermore, US and UK tax advisors consistently encounter founders who have built significant value in their companies without ever modeling what an IPO would cost them across both tax systems simultaneously — a gap that, by the time the company is on the roadshow, is too late to fill through planning rather than retrospective damage control. Consequently, pre-IPO equity planning for transatlantic founders is the single most financially consequential tax engagement in the UK startup ecosystem for US-connected founders, and the window for effective action closes weeks before the IPO process formally begins.

This article is written for US-citizen founders who hold shares in UK-incorporated companies approaching an IPO or major liquidity event in 2026, and for US and UK tax advisors who advise them. By the end of this guide, you will understand the key US and UK tax issues that arise at IPO for transatlantic founders, the planning actions that must be taken before the IPO process begins, and the mistakes that most commonly destroy founder value at the point of liquidity.

What Do US and UK Tax Advisors Do for Pre-IPO Founders?

US and UK tax advisors are cross-border tax professionals who advise clients on both US federal and UK tax obligations, with the expertise to model how those two systems interact for a single economic event — such as a company IPO. Furthermore, in the pre-IPO context, this requires combining knowledge of US capital gains rates, the Section 1202 QSBS exclusion, the Section 1248 CFC recharacterisation rules, the Section 83(b) election, and the Qualified Small Business Stock holding period requirements with UK knowledge of Business Asset Disposal Relief qualifying conditions, the UK CGT lock-up period regime for IPO shares, Enterprise Management Incentive option treatment, and the interaction between the companies act structure and US tax classifications. Specifically, the pre-IPO planning window — typically the twelve to eighteen months before the anticipated listing date — is the period in which structural decisions can still be made, elections can still be filed, and the founder's equity position can be reorganized to optimize the combined US and UK tax outcome at liquidity.

The IRS guidance on capital gains and qualified small business stock is at https://www.irs.gov/taxtopics/tc409. Additionally, the HMRC guidance on Business Asset Disposal Relief is at https://www.gov.uk/hmrc-internal-manuals/capital-gains-manual/cg63950.

Why Pre-IPO Planning Matters More Than Ever in 2026

The UK IPO Market Recovery and US Cross-Listings

The UK IPO market is recovering after a period of reduced activity, with the London Stock Exchange's reforms to its listing rules — implemented in July 2024 — designed to attract more technology and growth companies to London rather than pursuing a US listing as the default exit route. Furthermore, these reforms have created a new category of dual-class share-structure listings that have specific implications for founders' equity arrangements and for the US tax treatment of dual-class shares at the entity level. Consequently, transatlantic founders in 2026 face a more complex set of listing venue decisions than at any point in the recent past — choosing between a London listing, a New York or Nasdaq listing, or a dual listing on both exchanges — with each option carrying distinct US and UK tax consequences that US and UK tax advisors must model before the listing venue decision is finalized. According to data from https://www.londonstockexchange.com, the LSE's new listing rules have already attracted several technology companies to London that would previously have defaulted to a US listing.

The Section 1202 QSBS Exclusion and UK Companies

Section 1202 of the Internal Revenue Code provides an exclusion of up to 100% of the capital gain on the sale of qualified small business stock for US taxpayers who hold eligible shares for more than five years. Furthermore, for a US-citizen founder of a UK-incorporated company, the QSBS exclusion is theoretically available — but only if the UK company is a C corporation for US tax purposes and meets the domestic US corporation test in Section 1202, which requires the company to be incorporated as a domestic C corporation under US law rather than as a UK private limited company. Consequently, most UK-incorporated companies do not qualify for the QSBS exclusion, which means US-citizen founders of UK startups lose access to one of the most generous capital gains tax exclusions in the US tax code simply because of the company's incorporation jurisdiction — a significant disadvantage compared with US-citizen founders of US-incorporated companies who can potentially exclude 100% of their founder gain from US federal capital gains tax.

The BADR Two-Year Qualifying Period and IPO Timing

Business Asset Disposal Relief is available at 14% (from April 2025) on the first £1 million of qualifying gains on the disposal of shares in a qualifying trading company, provided the founder has held at least 5% of the ordinary shares and voting rights throughout the two years immediately before the disposal, and has been an employee or officer of the company throughout that period. Furthermore, at an IPO, the disposal of shares by the founder — whether through a sale of existing shares as part of the IPO offer or through the sale of shares from an employee share scheme exercise — is the disposal for BADR purposes, and the two-year clock must be running at that point. Consequently, a founder who reorganizes their equity position in the eighteen months before the IPO — for example, by converting growth shares to ordinary shares, exercising options over new shares, or accepting a share-for-share exchange as part of a pre-IPO restructuring — must confirm that the BADR qualifying period continues to run through the restructuring event and is not restarted.

Key US and UK Tax Issues for Transatlantic Founders at IPO

The Section 1248 Ordinary Income Recharacterization

For US-citizen founders who own shares in a UK company that has been a controlled foreign corporation during any part of their holding period, the gain on the disposal of those shares at IPO is potentially subject to the Section 1248 recharacterisation — converting what would otherwise be long-term capital gain (taxed at 20% plus 3.8% NIIT) into ordinary income (taxed at up to 37% plus 3.8% NIIT) to the extent of the company's accumulated earnings and profits attributable to the US founder's period of ownership. Furthermore, for high-growth UK startups that have generated significant retained earnings before the IPO — either from trading profit or from the capitalization of development expenditure — the accumulated E&P can be very large, producing a Section 1248 ordinary income component that represents a substantial proportion of the total IPO gain. Additionally, US and UK tax advisors must complete the E&P calculation for every year of the CFC holding period before the IPO — since the E&P determines the Section 1248 ordinary income — and that calculation requires access to the company's UK statutory accounts for every year since incorporation.

The Lock-Up Period and UK CGT

At most IPOs, founder shareholders are subject to a lock-up period — typically 180 days to twelve months after the IPO date — during which they cannot sell their shares. Furthermore, for UK CGT purposes, the disposal of shares subject to a lock-up is generally treated as occurring when the lock-up expires, and the shares are actually sold, rather than when the IPO occurs. However, for US tax purposes, the tax treatment of IPO shares subject to a lock-up depends on whether the lock-up constitutes a substantial risk of forfeiture under IRC Section 83, and if it does, the taxable event is also deferred until the lock-up expires. Consequently, the interaction between the UK CGT lock-up rules and the US Section 83 analysis must be confirmed with US and UK tax advisors before the IPO date, as differing treatment in each country can create a timing mismatch that complicates foreign tax credit planning.

The CFC Form 5471 Obligation and IPO Disclosure

A US-citizen founder who holds 10% or more of a UK company before the IPO must have been filing Form 5471 annually for every year of the holding period. Furthermore, at the IPO, the company transitions from a private limited company — which may have been a CFC — to a public company, and the founder's post-IPO shareholding may fall below the 10% CFC threshold as new shares are issued to public investors. Consequently, the IPO year is typically the final year in which Form 5471 is required — assuming the founder's diluted post-IPO holding falls below 10% — and the final Form 5471 must report the company's E&P at the time of the IPO, since that E&P feeds directly into the Section 1248 calculation for the IPO disposal. Additionally, any missed Form 5471 filings from prior years must be regularised before the IPO, since the company's US legal counsel will typically conduct a US tax compliance review as part of the IPO due diligence process.

Pre-IPO Equity Planning: Step by Step for Transatlantic Founders

Step 1 — Conduct a full cross-border equity audit 18 months before the IPO.

Compile a complete schedule of every class of shares and options held by every US-person founder, director, and employee, confirming the acquisition date, cost basis, current fair market value, and any conditions attached to each holding. Furthermore, confirm the company's CFC status for each year since incorporation and identify the years for which Form 5471 should have been filed. Additionally, calculate the company's accumulated earnings and profits for the full CFC period to produce a preliminary Section 1248 ordinary income estimate for use in the pre-IPO tax modeling.

Step 2 — Assess BADR qualifying status for each US founder's shareholding.

Confirm that each US-citizen founder holds at least 5% of the ordinary shares and voting rights of the company, has been an employee or officer throughout the two years preceding the anticipated IPO date, and that the company is a qualifying trading company throughout that period. Furthermore, assess whether any planned pre-IPO restructuring — share consolidations, growth share conversions, or new share issuances to incoming investors — will affect the BADR qualifying shareholding percentage or restart the two-year qualifying period. Additionally, model the BADR relief at the anticipated post-April 2025 rate of 14% against the UK CGT at the standard 24% rate to quantify the UK tax saving from BADR for each founder's anticipated disposal.

Step 3 — Model the combined US and UK tax on the IPO disposal for each founder.

Using the preliminary Section 1248 E&P calculation from Step 1, model the combined US and UK tax on each founder's anticipated IPO disposal — splitting the gain between the Section 1248 ordinary income component and the remaining long-term capital gain component. Furthermore, calculate the foreign tax credit available from the UK BADR CGT against the US capital gains tax on the capital gain component, and assess the availability of any treaty-based credit position on the ordinary income component. Additionally, model the exchange-rate impact on the US dollar gain using the anticipated IPO-date exchange rate, and compare the result with the sterling gain to identify any material currency gain or loss that would affect the US tax base.

Step 4 — Review the Section 83(b) election position for any unvested equity.

Identify any restricted shares or growth shares held by US-citizen founders that are subject to vesting conditions at the anticipated IPO date, and confirm whether a Section 83(b) election was made at the time of grant. Furthermore, where Section 83(b) elections were not made. The 30-day window has passed. Assess the US tax consequences of the unvested shares at IPO, since shares that vest at or shortly after the IPO as a result of the liquidity event trigger ordinary income at the IPO date's fair market value rather than at the original grant-date value. Additionally, for any new equity awards to US-citizen founders planned in the pre-IPO period, confirm that Section 83(b) elections are made within the thirty-day window from the date of grant. The IRS Section 83 guidance is at https://www.irs.gov/pub/irs-drop/rr-83-22.pdf.

Step 5 — Regularise any missed Form 5471 filings before IPO due diligence.

Complete the Form 5471 catch-up filings for any years in which the obligation was not met, using the IRS streamlined procedures for non-wilful non-compliance or the Delinquent International Information Return Submission Procedures for cases where the income tax returns are current. Furthermore, timing is critical — the streamlined procedures are only available where no IRS examination has been opened, and the IPO due diligence process conducted by the company's US legal counsel may include a disclosure to the underwriters that could be construed as an IRS notification. Consequently, the Form 5471 regularisation should be completed at least six months before the anticipated IPO date to ensure the IPO process does not catch it.

Step 6 — Implement the post-IPO compliance programme for US founders.

Once the IPO is complete, establish the going-forward compliance program for US-citizen founders whose post-IPO shareholding falls below the 10% CFC threshold — transitioning from annual Form 5471 reporting to annual Form 8938 FATCA reporting for the listed share position and FBAR reporting for any brokerage accounts holding the listed shares. Furthermore, model the US and UK tax on any post-IPO share sales — including sales under lock-up expiry — using the correct US cost basis established from the pre-IPO equity audit. Additionally, confirm the annual dividend reporting obligations where the newly public company pays dividends to US-citizen shareholders following the IPO.

Case Study: US-UK Dual Founder, London Fintech, Nasdaq IPO

Our team was engaged by two co-founders of a London-based payment technology company — one a US citizen who had lived in the UK for eight years, and one a UK citizen — who were preparing for a Nasdaq listing at an anticipated valuation of approximately £320 million. The US-citizen founder held 18% of the company's shares with a cost basis of £12,000 (nominal value at incorporation) and an anticipated IPO value of approximately £57.6 million. He had never filed a US income tax return, a Form 5471, or an FBAR for any year since the company's incorporation six years earlier.

After conducting the full pre-IPO equity audit, we identified that the company had been a CFC throughout the holding period and that Form 5471 should have been filed for each of the six years. Furthermore, the company's accumulated earnings and profits from its trading activities over the six years amounted to approximately £8.4 million, of which the US founder's 18% share was approximately £1.51 million. Consequently, the Section 1248 ordinary income recharacterization on the IPO disposal would convert approximately $1.9 million of the anticipated $72.6 million US dollar gain from long-term capital gain into ordinary income taxed at 40.8% rather than 23.8% — producing approximately $324,000 in additional US tax compared with full capital gain treatment. Additionally, the BADR qualifying conditions confirmed that 14% UK CGT applied to the full sterling gain, generating approximately £8.03 million in UK tax on the £57.6 million gain.

We regularised the six years of missed Form 5471 filings and three years of missed income tax returns through the IRS streamlined procedures, with a 5% penalty on the highest FBAR balance of approximately $180,000, producing a streamlined penalty of $9,000. Furthermore, we modeled the foreign tax credit from the UK BADR CGT of approximately $10.1 million (converted) against the US capital gains tax on the non-recharacterized portion of the gain, thereby eliminating the US capital gains tax on the capital gains component and producing a credit carryforward. Additionally, we confirmed that the US founder's post-IPO shareholding would fall to approximately 11% after the IPO dilution — still above the 10% CFC threshold — meaning Form 5471 would continue to be required for the IPO year but not thereafter, assuming the founder sold further shares post lock-up expiry. The net US federal tax on the IPO disposal was approximately $779,000 — entirely attributable to the Section 1248 ordinary income component — on a $72.6 million gain, after all credits and deductions.

Common Mistakes Transatlantic Founders Make Before IPO

Mistake 1 — Assuming the IPO Gain Is Entirely a Capital Gain

The most common mistake is modeling the US tax on the IPO disposal as though the entire gain were a long-term capital gain, without completing the Section 1248 E&P analysis that determines the ordinary-income recharacterization. Furthermore, for high-growth startups with significant retained earnings — even where those earnings were predominantly reinvested in the business rather than distributed — the E&P can be very large, producing a Section 1248 ordinary income component that significantly increases the effective US tax rate on the IPO proceeds. The correct approach requires the E&P calculation for each year of the CFC holding period before any US tax modeling is prepared, and this analysis should be completed at least 12 months before the anticipated IPO date.

Mistake 2 — Not Regularising Form 5471 Before IPO Due Diligence

US founders who have not filed Form 5471 for prior years frequently defer the regularisation until after the IPO, assuming they can address it at their convenience following the listing. Furthermore, the IPO due diligence process — conducted by the underwriters' legal counsel for a US listing — will typically ask the US founder directly about their US tax compliance, and a disclosure of missed Form 5471 filings at that stage can complicate the IPO timeline and the underwriters' comfort with the transaction. The correct approach is to complete the Form 5471 regularisation at least six months before the anticipated IPO date, before any due diligence process begins. The IRS streamlined procedures are at https://www.irs.gov/individuals/international-taxpayers/streamlined-filing-compliance-procedures.

Mistake 3 — Missing the Section 83(b) Election on Pre-IPO Restricted Shares

US founders who receive restricted shares or growth shares subject to performance or time vesting in the years before the IPO frequently miss the Section 83(b) election, which must be filed within thirty days of the grant. Furthermore, where the shares vest at or around the IPO date as a result of a liquidity event vesting trigger — a common provision in UK startup shareholders' agreements — the vesting is treated as a compensation event in the IPO year at the IPO price, producing ordinary income on the full value rather than at the lower grant-date value. The correct approach is to assess every share award made to US-citizen founders and employees in the pre-IPO period for Section 83(b) election eligibility and to file the election within the thirty-day window for every qualifying award.

Mistake 4 — Not Modelling the Lock-Up Period Tax Timing

Where the founder's IPO share sale is subject to a lock-up period, the US tax timing of the gain depends on whether the lock-up constitutes a substantial risk of forfeiture under Section 83. Furthermore, a mismatch between the UK and US tax years in which the gain is recognized can affect the foreign tax credit allocation and produce an unexpected residual US tax liability in one year. In contrast,e the UK tax credit appears in a different year. The correct approach requires a specific Section 83 analysis of the lock-up terms before the IPO to confirm the US tax timing, and the foreign tax credit must be modeled using the confirmed timing for both the US and UK charges.

Mistake 5 — Not Assessing QSBS Eligibility for US-Incorporated Subsidiaries

Some transatlantic founders hold their stake in the company partly through a US-incorporated subsidiary or holding entity — particularly where the company was originally incorporated in the US before moving its primary operations to the UK. Furthermore, where the US entity is a domestic C corporation that meets the Section 1202 QSBS requirements, the founder's shares in the US entity may qualify for the 100% capital gains exclusion if held for more than five years — a benefit that is unavailable for direct holdings of UK company shares. The correct approach is to review the full corporate structure for each US-citizen founder, assess whether any US-incorporated entity in the chain qualifies for Section 1202 treatment, and confirm whether a QSBS election was made and has been maintained. The IRS Section 1202 guidance is at https://www.irs.gov/pub/irs-drop/n-2023-28.pdf.

Mistake 6 — Engaging Only UK Advisers for the IPO Tax Review

Perhaps the most consequential mistake is relying exclusively on UK tax advisers for the pre-IPO equity review, assuming they will identify and address the US tax dimensions of the founder's position. Furthermore, UK solicitors and accountants who advise on IPO transactions are experts in the UK capital gains and BADR analysis. Still, they are not trained in Section 1248, the QSBS exclusion, the Section 83(b) election, or Form 5471 — all of which are essential elements of the US founder's pre-IPO planning. The correct approach is to engage US and UK tax advisors simultaneously, not sequentially, so that the US and UK analyses can be coordinated from the outset rather than discovering conflicts between the two systems after planning decisions have already been made.

Get in Touch

At US-UK Tax, our team of Chartered Tax Advisers (CTA), Enrolled Agents (EA), and Certified Public Accountants (CPA) — members of the Chartered Institute of Taxation (CIOT) and the American Institute of CPAs (AICPA) — are the US and UK tax advisors that transatlantic founders turn to for pre-IPO equity planning across both systems. Furthermore, we conduct the full pre-IPO equity audit — Section 1248 E&P analysis, BADR qualifying conditions review, Section 83(b) election assessment, Form 5471 regularisation, and combined US and UK tax modeling on the anticipated IPO disposal — as a coordinated engagement that addresses every cross-border dimension of the founder's equity position before the IPO process begins. We work directly with UK corporate lawyers, US securities counsel, and investment banks to ensure that the tax analysis is integrated into the overall IPO planning timeline.

Contact our team today to begin a confidential pre-IPO equity planning review. Email hello@us-uktax.com, call 0333-8807974, or visit https://www.us-uktax.com/contact/ to book a consultation.

Conclusion

Pre-IPO equity planning for transatlantic founders is the most financially consequential cross-border tax engagement in the UK startup ecosystem, and the window for effective action closes long before the IPO roadshow begins. Furthermore, the combination of Section 1248 ordinary income recharacterization, BADR qualifying conditions, Section 83(b) missed elections, Form 5471 non-compliance, and the QSBS exclusion's unavailability for UK-incorporated companies creates complexity that no single-jurisdiction adviser can navigate alone. Consequently, engaging US and UK tax advisors who understand both systems simultaneously — and who can model the combined US and UK tax outcome before any structural decisions are made — is the only way to ensure that founder value is preserved rather than destroyed at the point of liquidity.

The three most important actions for any transatlantic founder preparing for an IPO are: first, commission a full cross-border equity audit and Section 1248 E&P analysis at least eighteen months before the anticipated listing date; second, regularise any missed Form 5471 filings before the IPO due diligence process begins — ideally at least six months before the anticipated listing; and third, review every US-citizen founder's restricted share and growth share holdings for missed Section 83(b) elections before the lock-up vesting triggers at IPO. Contact US-UK Tax at hello@us-uktax.com or call 0333-8807974 to begin your pre-IPO planning review today.

Contact Us

US-UK Tax | hello@us-uktax.com | 0333-8807974

https://www.us-uktax.com

FAQs

Q: What is the Section 1248 recharacterization, and how does it affect IPO gains?

Section 1248 converts capital gain on CFC shares into ordinary income to the extent of accumulated earnings and profits. This portion is taxed at up to 40.8% rather than 23.8%, significantly increasing the effective US tax rate on an IPO gain.

Q: Can a UK-incorporated company qualify for the Section 1202 QSBS exclusion?

Generally no. Section 1202 requires that a corporation be a domestic US C corporation. UK private limited companies are treated as foreign corporations for US purposes and therefore do not qualify. US-citizen founders of UK companies lose access to the 100% capital gains exclusion as a result.

Q: Does BADR apply to shares sold at IPO?

Yes, if the founder holds at least 5% of ordinary shares and voting rights and has been an employee or officer throughout the two years before the IPO disposal. The rate is 14% from April 2025 on the first £1 million of qualifying gains.

Q: What is the Section 83(b) election, and when must it be filed?

A Section 83(b) election allows a US employee to pay tax on restricted shares at the grant date value rather than the vesting value. It must be filed within 30 days of the grant date — no extensions are permitted. Missing this window permanently forfeits the election.

Q: Must Form 5471 be filed in the year of the company's IPO?

Yes, for the final year of CFC ownership — typically the IPO year — Form 5471 must be filed. The final E&P calculation on this form feeds directly into the Section 1248 ordinary income calculation on the IPO disposal return.

Q: How does the lock-up period affect the US tax timing of an IPO gain?

If the lock-up constitutes a substantial risk of forfeiture under IRC Section 83, the US taxable event is deferred until the lock-up expires. This can create a timing mismatch with the UK CGT and affect the allocation of foreign tax credits between tax years.

Q: Should I engage UK advisers or US advisers for pre-IPO equity planning?

Both, simultaneously. UK advisers understand BADR and the corporate structure; US advisers understand Section 1248, QSBS, and Form 5471. Engaging them sequentially rather than together consistently produces conflicts that destroy founder value at IPO.

Q: How long does a pre-IPO cross-border equity audit take?

Typically, three to six months for a thorough engagement, including the Section 1248 E&P calculation for all CFC years. Starting at least 18 months before the anticipated IPO date allows time for regularisation and restructuring before the process begins.